Literature DB >> 2640778

Retained placenta in cattle: the effect of treatment or nontreatment on puerperal diseases and subsequent fertility.

M Heinonen, K Heinonen.   

Abstract

In order to examine the effect of treated and untreated retained placenta (RP) on fertility and on the occurrence of puerperal and fertility diseases, the records of 248 cows with RP were examined: 199 cows were treated with intrauterine tetracycline or systemic therapeutics, and 49 were left untreated. One hundred and ninety-six herd mates without RP served as controls. The fertility of the cows with RP was lower than that of the controls. The effect of treatment on fertility was neither beneficial nor harmful. The untreated cows with RP seemed to be treated more often for endometritis and repeat breeding than either the treated animals or the controls. Mastitis within 1 week after calving was more common in both groups of RP cows than in the controls. Most cases of mastitis in the treated RP group could be diagnosed at the time of RP treatment.

Entities:  

Mesh:

Year:  1989        PMID: 2640778      PMCID: PMC8142196     

Source DB:  PubMed          Journal:  Acta Vet Scand        ISSN: 0044-605X            Impact factor:   1.695


  4 in total

1.  The effect of mild fat infiltration in the liver on the fertility of Finnish Ayrshire cows.

Authors:  K Heinonen; Y Gröhn; L A Lindberg; M Alanko
Journal:  Acta Vet Scand       Date:  1987       Impact factor: 1.695

2.  Factors associated with the incidence of retained placentas.

Authors:  L D Muller; M J Owens
Journal:  J Dairy Sci       Date:  1974-06       Impact factor: 4.034

3.  Retained placenta in cattle -- incidence, clinical data and effects on fertility.

Authors:  I Dyrendahl; J Mattson; B Pehrson
Journal:  Zentralbl Veterinarmed A       Date:  1977-09

4.  The effect of retained placenta and metritis complex on reproductive performance in dairy cattle -- a case control study.

Authors:  W C Sandals; R A Curtis; J F Cote; S W Martin
Journal:  Can Vet J       Date:  1979-05       Impact factor: 1.008

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.